A detailed history of Access Investment Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Access Investment Management LLC holds 60 shares of VRTX stock, worth $24,198. This represents 0.01% of its overall portfolio holdings.

Number of Shares
60
Holding current value
$24,198
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 05, 2025

BUY
$421.16 - $509.5 $25,269 - $30,570
60 New
60 $26,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $104B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Access Investment Management LLC Portfolio

Follow Access Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Access Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Access Investment Management LLC with notifications on news.